Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
02/1995
02/23/1995CA2169280A1 Amidine derivatives with nitric oxide synthetase activities
02/23/1995CA2169187A1 Use of phenols and phenol derivatives as pharmaceutical agents with a fibrinogen-lowering action
02/23/1995CA2168211A1 Method of preventing neutrophil mediated connective tissue damage
02/23/1995CA2167716A1 Treatment of adverse effects associated with administration of extracellular hemoglobin
02/23/1995CA2165567A1 Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelien antagonists
02/22/1995EP0639644A1 New macrolides and their use
02/22/1995EP0639580A1 Sphingoglycolipid
02/22/1995EP0639575A1 Bicyclic heterocycles, medicaments comprising these compounds and processes for their production
02/22/1995EP0639552A1 Napthalenederivatives, their preparation and pharmaceutical compositions containing them
02/22/1995EP0639368A1 Scalp care product composition
02/22/1995EP0639225A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
02/22/1995EP0639201A1 14,16beta-ETHANO-15beta,16' -CYCLO-14beta-ESTRA-1,3,5(10)-TRIENES
02/22/1995EP0639187A1 Phenylderivate as inhibitors of atp citrate lyase
02/22/1995EP0639181A1 Pyridine-substituted benzyl alcohols as leukotriene antagonists
02/22/1995EP0639079A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
02/22/1995EP0639076A1 Use of guanylate cyclase inhibitors in the treatment of shock
02/22/1995EP0526502B1 Phenolic amine depigmenting and antimelanoma agents
02/22/1995CN1099040A Linear adhesion inhibitor
02/22/1995CN1098909A Antioxidant cardioprotective use of, and method of treatment using, hydroxycarbazole compounds
02/22/1995CN1098908A Antioxidant neuroprotective use of, and method of treatment using hydroxycarbazole compounds
02/22/1995CN1027695C Heterocyclic-NMDA antagonists
02/21/1995US5391776 Steroid derivatives
02/21/1995US5391758 Heterocyclic amide derivatives
02/21/1995US5391754 Oximination a tetrahydropyridin-3-aldehyde, alkylation with a halides, salt formation
02/21/1995US5391731 Pyrroloazepine derivatives
02/21/1995US5391569 Treating osteoporosis, inflammatory disorders
02/21/1995US5391556 Thrombin inhibitors
02/21/1995US5391550 Compositions of matter and methods for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
02/21/1995US5391547 Method using 5,10,15,20-tetrakis(4-carboxyphenyl)porphine for treating cancers of the lung
02/21/1995US5391328 Apparatus for introducing and bonding gas into water
02/19/1995CA2129906A1 Naphthalene derivatives, process for their preparation and pharmaceutical compositions containing them
02/17/1995CA2130044A1 Macrolides and the use thereof
02/16/1995WO1995004819A1 NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-β FAMILY
02/16/1995WO1995004752A1 Therapeutic peptide derivatives
02/16/1995WO1995004735A1 Matrix metalloprotease inhibitors
02/16/1995WO1995004729A1 Amide derivatives as 5ht1d receptor antagonists
02/16/1995WO1995004720A2 Gastrin and cck receptor ligands
02/16/1995WO1995004713A1 2-aminoindans as selective dopamine d3 ligands
02/16/1995WO1995004538A1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis
02/16/1995WO1995004535A1 Estrogenic compounds as anti-mitotic agents
02/16/1995WO1995004530A1 Endothelin receptor antagonists
02/16/1995WO1995004526A1 Lupane triterpenoid derivatives
02/16/1995WO1995004520A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection
02/16/1995CA2169291A1 Lupane triterpenoid derivatives
02/16/1995CA2168791A1 Matrix metalloprotease inhibitors
02/16/1995CA2167154A1 Gastrin and cck receptor ligands
02/16/1995CA2146547A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection
02/16/1995CA2142349A1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis
02/15/1995EP0638572A1 Bicyclic derivatives of imidazole, process for their preparation, intermediates; their application as medicaments and pharmaceutical compostions containing them
02/15/1995EP0638548A1 Urea-subsituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
02/15/1995EP0638321A1 Ipriflavone and pharmaceutical compositions and their use for bone defect substitution
02/15/1995EP0638317A1 Pharmaceutical composition
02/15/1995EP0638311A1 Rejection inhibitor for transplants and il-1 production inhibitor
02/15/1995EP0638080A1 7-DISUBSTITUTED-METHYL-4-OXO-3H -,5H --PYRROLO 3,2-d -]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME
02/15/1995EP0638075A1 Thiazole or imidazole derivatives as maillard reaction inhibitors
02/15/1995EP0637933A1 Method and kit for imaging and treating organs and tissues
02/15/1995EP0339046B1 Leukotriene b 4 analogs
02/15/1995CN1098715A 1H-indole-3-acetamide spla2 inhibitors
02/15/1995CN1098714A 1H-indole-3-acetic acid hydrazide spla2 inhibitors
02/15/1995CN1027640C Process for the production of new trifluoromethyl ketone substituted peptide derivatives
02/14/1995US5389684 Naphthalene carboxamides
02/14/1995US5389666 Administering for treatment and prevention of thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer or hypertension
02/14/1995US5389660 Substituted imidazo-fused 5-membered ring heterocycles as angiotensin II antagonists
02/14/1995US5389659 C-linked pyrazole derivatives
02/14/1995US5389650 Antiinflammatory agents, anticoagulants, antispasmodic agents
02/14/1995US5389644 For increasing sensitivity of tumor cells to antitumor agents without side effects
02/14/1995US5389643 Aminobenzoic acid derivatives useful for treating gastro-intestinal conditions
02/14/1995US5389642 Exhibit antagonistic properties toward angiotensin(II); useful for treatment of hypertensioni, aldosteronism, cardiac insufficiency, increased intraocular pressure and disorders of the central nervous system
02/14/1995US5389614 Anticoagulants
02/14/1995US5389612 Phosphonic peptide inhibitors of bacterial collagenases
02/14/1995US5389369 Halo peroxidase containing compositions for killing yeast and sporular microorganisms
02/14/1995CA2130020A1 Sulphonylbenzyl-substituted benzimidazoles, a process for their preparation and their use in medicaments
02/14/1995CA1334390C Glycoprotein growth modulation materials
02/09/1995WO1995004277A1 A method for preparing and selecting pharmaceutically useful non-peptide compounds from a structurally diverse universal library
02/09/1995WO1995004135A1 Fungicidal methods and compositions for killing yeast and sporular microorganisms
02/09/1995WO1995004078A1 Cell adhesion protein complexes with copper
02/09/1995WO1995004055A1 Thiazole derivatives as lipoxygenase inhibitors
02/09/1995WO1995004052A1 Methylguanidine derivatives, methods for preparing same and compositions containing said derivatives
02/09/1995WO1995004051A1 Piperazine compounds used in therapy
02/09/1995WO1995004049A1 PIPERAZINE DERIVATIVES AS α1A-ADRENERGIC RECEPTOR ANTAGONISTS
02/09/1995WO1995004045A1 Compounds as pde iv and tnf inhibitors
02/09/1995WO1995004042A1 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists
02/09/1995WO1995004040A1 Perhydroisoindole derivatives as p substance antagonists
02/09/1995WO1995004039A1 2-phenylpyrrole derivatives as dopamine d3 receptor antagonists
02/09/1995WO1995004037A1 2-(2-hydroxyphenyl)-5-(n-phenylmethyl-aminomethyl)-pyrroles as antipsychotic agents
02/09/1995WO1995004036A1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors
02/09/1995WO1995004033A1 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
02/09/1995WO1995004030A1 Therapeutic compound - fatty acid conjugates
02/09/1995WO1995003821A1 Prosaposin and cytokine-derived peptides as therapeutic agents
02/09/1995WO1995003804A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict
02/09/1995WO1995003799A1 Use of benzydamine in the treatment of pathological conditions caused by tnf
02/09/1995WO1995003794A1 3-cyano-3-(3,4-disubstituted)phenylcyclohexyl-1-carboxylates
02/09/1995WO1995003780A1 Cosmetic or pharmaceutical and particularly dermatological composition containing an extract of tephrosia, particularly tephrosia purpurea
02/09/1995WO1995003764A1 Skin patches and methods for providing testosterone
02/09/1995WO1994022437A3 Method for treating amyloidosis
02/09/1995DE4428025A1 Inhibitoren der Acyl-Enzym-A-Cholesterin-O-Acyl-Transferase mit therapeutischer Wirksamkeit, ihre Verwendung und sie enthaltende pharmazeutische Zusammensetzungen Inhibitors of acyl-enzyme A: cholesterol O-acyl transferase with therapeutic efficacy, their use and pharmaceutical compositions containing them
02/09/1995DE4325900A1 Trisubstituted pyrimido[5,4-d]pyrimidines for the modulation of multi-drug resistance, medicaments containing these compounds and processes for their production
02/09/1995CA2168886A1 A method for preparing and selecting pharmaceutically useful non-peptide compounds from a structurally diverse universal library
02/09/1995CA2168443A1 Piperazine derivatives as .alpha.1a-adrenergic receptor antagonists
02/09/1995CA2168262A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict